These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30430214)

  • 1. Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring.
    Łuszczyńska P; Pawiński T; Kunicki PK; Durlik M; Augustyniak-Bartosik H; Hurkacz M
    Eur J Clin Pharmacol; 2019 Mar; 75(3):371-379. PubMed ID: 30430214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.
    Kittanamongkolchai W; Rukrung C; Supasiri T; Lertjirachai I; Somparn P; Chariyavilaskul P; Avihingsanon Y
    Lupus; 2013 Jun; 22(7):727-32. PubMed ID: 23651860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia.
    Atcheson BA; Taylor PJ; Kirkpatrick CM; Duffull SB; Mudge DW; Pillans PI; Johnson DW; Tett SE
    Ther Drug Monit; 2004 Jun; 26(3):284-6. PubMed ID: 15167629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring.
    Zabotti A; Baraldo M; Quartuccio L; Sacco S; De Marchi G; De Vita S
    Clin Rheumatol; 2015 Jan; 34(1):171-4. PubMed ID: 25249327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis: A Review of Current Literature.
    Łuszczyńska P; Pawiński T
    Ther Drug Monit; 2015 Dec; 37(6):711-7. PubMed ID: 26034895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.
    Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
    Br J Clin Pharmacol; 2015 Nov; 80(5):1064-75. PubMed ID: 25959850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN).
    Ranganathan D; Abdul-Aziz MH; John GT; McWhinney BC; Fassett RG; Healy H; Kubler P; Lim A; Lipman J; Purvey M; Roberts M; Reyaldeen R; Ungerer J; Roberts JA
    Ther Drug Monit; 2019 Dec; 41(6):703-713. PubMed ID: 31219949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.
    Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):993-1004. PubMed ID: 28536776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
    Yap DYH; Tam CH; Yung S; Wong S; Tang CSO; Mok TMY; Yuen CKY; Ma MKM; Lau CS; Chan TM
    Nephrol Dial Transplant; 2020 May; 35(5):810-818. PubMed ID: 30215770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.
    Punyawudho B; Lertdumrongluk P; Somparn P; Kittanamongkolchai W; Traitanon O; Avihingsanon Y; Vadcharavivad S
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):272-80. PubMed ID: 22456298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Indian Patients With Lupus Nephritis.
    Koloskoff K; Panwar R; Rathi M; Mathew S; Sharma A; Marquet P; Benito S; Woillard JB; Pattanaik S
    Ther Drug Monit; 2024 Oct; 46(5):567-574. PubMed ID: 38723153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis.
    Wuttiputhanun T; Naiyarakseree N; Udomkarnjananun S; Kittanamongkolchai W; Asada L; Chariyavilaskul P; Townamchai N; Avihingsanon Y
    Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38233072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study.
    Zhang L; Chen L; Liu X; Huang Z; Zheng Y; Tang K; Jiang X; Chen P
    Rheumatology (Oxford); 2024 Sep; 63(SI2):SI180-SI187. PubMed ID: 38730553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of trough mycophenolic acid levels for the management of lupus nephritis.
    Pourafshar N; Karimi A; Wen X; Sobel E; Pourafshar S; Agrawal N; Segal E; Mohandas R; Segal MS
    Nephrol Dial Transplant; 2019 Jan; 34(1):83-89. PubMed ID: 29548021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
    Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
    Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.
    Romano-Aguilar M; Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Martínez-Martínez MU; Abud-Mendoza C; Romano-Moreno S
    Lupus; 2020 Aug; 29(9):1067-1077. PubMed ID: 32539658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis.
    Godron-Dubrasquet A; Woillard JB; Decramer S; Fila M; Guigonis V; Tellier S; Morin D; Sordet M; Saint-Marcoux F; Harambat J
    Pediatr Nephrol; 2021 Feb; 36(2):341-347. PubMed ID: 32856157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.